Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis
Details
Publication Year 2017, Volume 6, Issue #2, Page e1267892
Journal Title
Oncoimmunology
Publication Type
Journal Article
Abstract
The cytokine-induced SH2-containing protein CIS belongs to the suppressor of cytokine signaling (SOCS) protein family. Here, we show the critical role of CIS in suppressing natural killer (NK) cell control of tumor initiation and metastasis. Cish-deficient mice were highly resistant to methylcholanthrene-induced sarcoma formation and protected from lung metastasis of B16F10 melanoma and RM-1 prostate carcinoma cells. In contrast, the growth of primary subcutaneous tumors, including those expressing the foreign antigen OVA, was unchanged in Cish-deficient mice. The combination of Cish deficiency and relevant targeted and immuno-therapies such as combined BRAF and MEK inhibitors, immune checkpoint blockade antibodies, IL-2 and type I interferon revealed further improved control of metastasis. The data clearly indicate that targeting CIS promotes NK cell antitumor functions and CIS holds great promise as a novel target in NK cell immunotherapy.
Publisher
Taylor & Francis
WEHI Research Division(s)
Molecular Immunology; Inflammation
PubMed ID
28344878
Rights Notice
Refer to copyright notice on published article.


Creation Date: 2017-05-15 01:16:29
Last Modified: 2018-04-05 02:44:48
An error has occurred. This application may no longer respond until reloaded. Reload 🗙